Nervonik Announces Completion of Groundbreaking First-in-Human Feasibility Study Demonstrating Nerve Sensing during Peripheral Nerve Stimulation in Multiple Anatomical Targets
LOS ANGELES, June 16, 2026 /PRNewswire/ -- Nervonik, a clinical-stage medical device company developing next-generation peripheral nerve stimulation (PNS) technologies, today announced the completion of a first-in-human feasibility study demonstrating the ability to record key nerve-related biosignals from 16 peripheral nerves in 8 chronic pain patients